Promising therapy for common form of eczema identified in early-stage trial

A therapy that targets the immune system showed promise for treating atopic dermatitis– the most common form of eczema– in a small proof-of-concept trial, led by scientists from the MRC Human Immunology Unit at the University of Oxford.
Source: Medical Research Council General News - Category: Research Source Type: news